MP08-17 BIOMARKER-TARGETED NOVEL COMBINATION FOR RENAL CELL CARCINOMA
2020
INTRODUCTION AND OBJECTIVE:The survival of patients with metastatic renal cell carcinoma (mRCC) is < 10% at 5-years, despite treatment. Hyaluronic acid (HA) promotes tumor growth and metastasis thr...
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI